Verastem reported $9.6M in Trade Creditors for its fiscal quarter ending in March of 2026.





Trade Creditors Change Date
AbbVie USD 33.3B 29.71B Jun/2026
Alaunos Therapeutics USD 732K 332K Jun/2026
AstraZeneca USD 23.57B 679M Sep/2026
Curis USD 6.74M 1.13M Mar/2026
Cytokinetics USD 25.96M 5.45M Sep/2026
Gilead Sciences USD 934M 260M Sep/2026
Incyte USD 235.37M 1.16B Sep/2026
Laboratory Of America USD 738M 49.5M Sep/2026
Novartis USD 4.24B 15M Sep/2026
Pfizer USD 4.07B 511M Sep/2026
Roche Holding CHF 5.54B 237M Jun/2026
TG Therapeutics USD 176.86M 36.83M Sep/2026
Verastem USD 9.6M 2.85M Mar/2026